Renal Denervation After the SPYRAL HTN-OFF MED Trial: Putting a Complex Study Into Context

Markus P Schlaich¹, Murray D Esler²

• ¹From the Dobney Hypertension Centre, School of Medicine-Royal Perth Hospital Unit, University of Western Australia (M.P.S.); Department of Cardiology (M.P.S.) and Department of Nephrology (M.P.S.), Royal Perth Hospital, Australia; and Neurovascular Hypertension and Kidney Disease Laboratory (M.P.S., M.D.E.) and Human Neurotransmitter Laboratory (M.D.E.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia. markus.schlaich@uwa.edu.au.+1